Omada Health, Inc. (NASDAQ:OMDA – Get Free Report) CFO Steven Cook sold 6,800 shares of the stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $21.86, for a total value of $148,648.00. Following the completion of the transaction, the chief financial officer directly owned 173,906 shares in the company, valued at approximately $3,801,585.16. This represents a 3.76% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
Omada Health Price Performance
Shares of NASDAQ:OMDA traded up $0.84 during mid-day trading on Monday, reaching $20.50. 961,447 shares of the company traded hands, compared to its average volume of 1,250,359. The firm has a market cap of $1.26 billion, a PE ratio of 410.00 and a beta of 1.86. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $26.92. The company’s 50 day moving average price is $22.63 and its 200-day moving average price is $17.97.
Omada Health (NASDAQ:OMDA – Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.10. The company had revenue of $87.83 million for the quarter, compared to the consensus estimate of $80.93 million. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. On average, research analysts predict that Omada Health, Inc. will post 0.09 earnings per share for the current fiscal year.
Institutional Trading of Omada Health
Analyst Upgrades and Downgrades
A number of equities analysts have recently issued reports on OMDA shares. Wall Street Zen raised Omada Health from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. BMO Capital Markets restated an “outperform” rating and set a $24.00 target price on shares of Omada Health in a research note on Friday, August 7th. JPMorgan Chase & Co. increased their price target on Omada Health from $26.00 to $30.00 and gave the company an “overweight” rating in a research note on Friday, August 14th. Citigroup restated an “outperform” rating on shares of Omada Health in a research note on Friday, August 14th. Finally, Citizens Jmp increased their price objective on shares of Omada Health from $27.00 to $32.00 and gave the company a “market outperform” rating in a research report on Friday, August 14th. Eleven equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Omada Health presently has an average rating of “Moderate Buy” and an average price target of $26.67.
Check Out Our Latest Research Report on Omada Health
Omada Health Company Profile
Omada Health, Inc is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines clinical care, health coaching, connected devices, digital tools and personalized support to help members improve health outcomes and manage conditions over time.
The company’s offerings address areas including diabetes, hypertension, weight health and musculoskeletal conditions. Omada’s programs are designed to support prevention and ongoing care through services such as remote monitoring, personalized health guidance, educational content and access to healthcare professionals.
Omada primarily serves members through employers, health plans and healthcare organizations in the United States.
Featured Stories
- Five stocks we like better than Omada Health
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.
